When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SPPI - Spectrum Pharma reports positive new data for poziotinib in lung cancer patients
Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals (NASDAQ:SPPI) has announced additional results from its Phase 2 (ZENITH20) trial, evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) patients with HER2 exon 20 insertion mutations (Cohort 2). Data were at the European Society for Medical Oncology Virtual Congress.
More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news,